Biomarkers and Monoclonal Antibody Treatment in AD
Cierra Keith, PhD, ABPP-CN Assistant Professor, Department of Behavioral Medicine & Psychiatry West Virginia University School of Medicine
Dr. Cierra Keith has been named as the inaugural Dementia SIG Co-Chair for the American Academy of Clinical Neuropsychology's new condition-based Special Interest Groups (SIGs) for Brain Injury and Dementia! An assistant professor and clinical neuropsychologist at the RNI, Dr. Keith has extensive experience with monoclonal antibody therapy for Alzheimer’s disease. She actively researches neuroimaging and cognitive aspects of Alzheimer’s and other neurodegenerative conditions and participates in clinical trials.
Copyright 2021, www.pnns.org. Contact postmaster@pnns.org for information and questions.
